Načítá se...
The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic
The emergence and global impact of COVID-19 has focused the scientific and medical community on the pivotal influential role of respiratory viruses as causes of severe pneumonia, on the understanding of the underlying pathomechanisms, and on potential treatment for COVID-19. The latter concentrates...
Uloženo v:
| Vydáno v: | Front Mol Biosci |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7773944/ https://ncbi.nlm.nih.gov/pubmed/33392263 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmolb.2020.610132 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|